Stocks end the week little changed. Meanwhile, Rivian jumps 22%, while Nike falls.

The FDA has been rumored to be evaluating whether or not to place a black box warning on vaccines for COVID-19.

Moderna MRNA announced that the Coalition for Epidemic Preparedness Innovations (“CEPI”) will invest up to $54.3 million in ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

Moderna Inc. will get as much as $54.3 million for a late-stage trial of its bird flu vaccine in a sign of how outside groups ...

The fresh capital provides another shot for Moderna's candidate against bird flu, which earlier this year lost its government ...

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 4% in the morning session after the company announced it would receive up to $54.3 million in funding from the Coalition for ...

The Coalition for Epidemic Preparedness Innovations said it will invest $54.3 million with Moderna to fund a Phase 3 trial of ...

Moderna will get up to $54.3 million in funding from a global coalition to support late-stage development of its experimental ...

Since he entered politics, President Donald Trump has been a regular on our end-of-year list of the most egregious and ...

As support from the U.S. government has evaporated, Moderna is leaning on an old ally to carry plans for its prospective mRNA ...

Moderna (MRNA) stock is in focus as CEPI vaccine coalition agreed to invest up to $54.3M to support a late-stage trial for the company's bird flu shot. Read more here.